Genomic and Clinical Characterization of IMP-1-Producing Multidrug-Resistant Acinetobacter bereziniae Isolates from Bloodstream Infections in a Brazilian Tertiary Hospital
Nenhuma Miniatura disponível
Data
2020-03-09
Autores
Brisolla Tavares, Lais Calissi
Vieira Cunha, Marcos Paulo
Vasconcellos, Francielli Mahnic de
Jesus Bertani, Amanda Maria de
Franco de Barcellos, Thays Almeida
Bueno, Mariana Sardinha
Santos, Carla Adriana
Sant'Ana, Daniel Almeida
Ferreira, Adriano Martison [UNESP]
Mondelli, Alessandro Lia [UNESP]
Título da Revista
ISSN da Revista
Título de Volume
Editor
Mary Ann Liebert, Inc
Resumo
Acinetobacter baumannii is the main species of the Acinetobacter genus; however, non-baumannii Acinetobacter (NBA) species causing infections have been described for the past years, as well as antimicrobial resistance. In this study, we describe the occurrence of two multidrug-resistant (MDR) IMP-1-producing Acinetobacter bereziniae isolates recovered from bloodstream infections in different patients but in the same intensive care unit among 134 carbapenem-resistant Acinetobacter screened. Antimicrobial susceptibility testing revealed resistance to carbapenems, extended spectrum, and antipseudomonad cephalosporins, amikacin, and trimethoprim-sulfamethoxazole. Both A. bereziniae isolates shared the same ApaI-pulsed-field gel electrophoresis (PFGE) pattern. Whole-genome sequencing of both isolates revealed that bla(IMP-1) was embedded into an In86 Class I integron carrying also sul1, aac(6 ')-31, and aadA genes. A new sequence type (ST1309 Pasteur) was deposited. The virulence genes lpxC and ompA, seen in A. baumannii, were detected in the A. bereziniae strains. Recognition of A. bereziniae causing invasive MDR infection underscores the role of NBA species as human pathogens especially in at-risk patients.
Descrição
Palavras-chave
Acinetobacter bereziniae, IMP-1, whole genome sequencing, next-generation sequencing, Ion Torrent
Como citar
Microbial Drug Resistance. New Rochelle: Mary Ann Liebert, Inc, 6 p., 2020.